BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17468049)

  • 1. Post-translational modifications regulate distinct functions of CARMA1 and BCL10.
    Thome M; Weil R
    Trends Immunol; 2007 Jun; 28(6):281-8. PubMed ID: 17468049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis.
    Takeda K; Harada Y; Watanabe R; Inutake Y; Ogawa S; Onuki K; Kagaya S; Tanabe K; Kishimoto H; Abe R
    Int Immunol; 2008 Dec; 20(12):1507-15. PubMed ID: 18829987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappaB signaling in lymphocytes: a new cast of characters.
    Lucas PC; McAllister-Lucas LM; Nunez G
    J Cell Sci; 2004 Jan; 117(Pt 1):31-9. PubMed ID: 14657271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10.
    Lobry C; Lopez T; Israël A; Weil R
    Proc Natl Acad Sci U S A; 2007 Jan; 104(3):908-13. PubMed ID: 17213322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of calmodulin with Bcl10 modulates NF-kappaB activation.
    Edin S; Oruganti SR; Grundström C; Grundström T
    Mol Immunol; 2010 Jul; 47(11-12):2057-64. PubMed ID: 20439115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.
    Wegener E; Krappmann D
    Sci STKE; 2007 May; 2007(384):pe21. PubMed ID: 17473310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A requirement for CARMA1 in TCR-induced NF-kappa B activation.
    Wang D; You Y; Case SM; McAllister-Lucas LM; Wang L; DiStefano PS; Nuñez G; Bertin J; Lin X
    Nat Immunol; 2002 Sep; 3(9):830-5. PubMed ID: 12154356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 induces NF-kappaB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells.
    Chan KK; Shen L; Au WY; Yuen HF; Wong KY; Guo T; Wong ML; Shimizu N; Tsuchiyama J; Kwong YL; Liang RH; Srivastava G
    J Pathol; 2010 Jun; 221(2):164-74. PubMed ID: 20235165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.
    Hosokawa Y
    Apoptosis; 2005 Jan; 10(1):25-34. PubMed ID: 15711920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CARD9 versus CARMA1 in innate and adaptive immunity.
    Hara H; Saito T
    Trends Immunol; 2009 May; 30(5):234-42. PubMed ID: 19359218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CaMKII targets Bcl10 in T-cell receptor induced activation of NF-κB.
    Oruganti SR; Edin S; Grundström C; Grundström T
    Mol Immunol; 2011 Jul; 48(12-13):1448-60. PubMed ID: 21513986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl10 is phosphorylated on Ser138 by Ca2+/calmodulin-dependent protein kinase II.
    Ishiguro K; Ando T; Goto H; Xavier R
    Mol Immunol; 2007 Mar; 44(8):2095-100. PubMed ID: 17052756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling.
    Lin X; Wang D
    Semin Immunol; 2004 Dec; 16(6):429-35. PubMed ID: 15541657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining the destiny of NF-kappa B after TCR ligation: it's CARMA1.
    Bunnell SC
    Mol Interv; 2002 Oct; 2(6):356-60, 338. PubMed ID: 14993411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and functional characterization of a BCL10-inhibitory peptide that represses NF-kappaB activation.
    Marasco D; Stilo R; Sandomenico A; Monti SM; Tizzano B; de Capua A; Varricchio E; Liguoro D; Zotti T; Formisano S; Ruvo M; Vito P
    Biochem J; 2009 Aug; 422(3):553-61. PubMed ID: 19538180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
    Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
    Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striking back at the activator: how IkappaB kinase terminates antigen receptor responses.
    Hinz M; Scheidereit C
    Sci STKE; 2007 May; 2007(384):pe19. PubMed ID: 17473308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway.
    Perkins ND
    Oncogene; 2006 Oct; 25(51):6717-30. PubMed ID: 17072324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of caspase recruitment domain (CARD) membrane-associated guanylate kinase 1 (CARMA1) and CARD9 in primary gastric B-cell lymphoma.
    Nakamura S; Nakamura S; Matsumoto T; Yada S; Hirahashi M; Suekane H; Yao T; Goda K; Iida M
    Cancer; 2005 Nov; 104(9):1885-93. PubMed ID: 16177990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells.
    McAllister-Lucas LM; Ruland J; Siu K; Jin X; Gu S; Kim DS; Kuffa P; Kohrt D; Mak TW; Nuñez G; Lucas PC
    Proc Natl Acad Sci U S A; 2007 Jan; 104(1):139-44. PubMed ID: 17101977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.